Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

[Are rare earths used in offshore windpower installations toxic?].

Goullé JP, Saussereau E, Lacroix C, Guerbet M, Cabanis EA.

Bull Acad Natl Med. 2012 Oct;196(7):1457-61. Review. French. No abstract available.

PMID:
23815027
2.

Nephrogenic systemic fibrosis: possible mechanisms and imaging management strategies.

Dawson P.

J Magn Reson Imaging. 2008 Oct;28(4):797-804. doi: 10.1002/jmri.21521. No abstract available.

PMID:
18821621
3.

Involvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an update.

Idée JM, Port M, Dencausse A, Lancelot E, Corot C.

Radiol Clin North Am. 2009 Sep;47(5):855-69, vii. doi: 10.1016/j.rcl.2009.06.006. Review.

PMID:
19744600
4.

Nephrogenic systemic fibrosis: the need for accurate case reporting.

Spinazzi A, Kirchin MA, Pirovano G.

J Magn Reson Imaging. 2009 May;29(5):1240; author reply 1241. doi: 10.1002/jmri.21741. No abstract available.

PMID:
19388104
5.

Gadolinium-containing MRI contrast agents: important variations on a theme for NSF.

Kuo PH.

J Am Coll Radiol. 2008 Jan;5(1):29-35. doi: 10.1016/j.jacr.2007.08.014. Review.

PMID:
18180006
6.

Multimodal MRI contrast agents.

Frullano L, Meade TJ.

J Biol Inorg Chem. 2007 Sep;12(7):939-49. Epub 2007 Jul 21. Review. No abstract available.

PMID:
17659368
7.

Extracellular gadolinium-based contrast media: an overview.

Bellin MF, Van Der Molen AJ.

Eur J Radiol. 2008 May;66(2):160-7. doi: 10.1016/j.ejrad.2008.01.023. Epub 2008 Mar 20. Review.

PMID:
18358659
8.

Lanthanides in magnetic resonance imaging.

Bottrill M, Kwok L, Long NJ.

Chem Soc Rev. 2006 Jun;35(6):557-71. Epub 2006 May 2. Review.

PMID:
16729149
9.

Safety update on the possible causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis.

Pedersen M.

J Magn Reson Imaging. 2007 May;25(5):881-3. No abstract available.

PMID:
17457808
10.

MRI contrast media are used to improve visualization of abnormal structures or lesions in various parts of the body. Introduction.

Thomsen HS, Marckmann P.

Eur J Radiol. 2008 May;66(2):153-9. doi: 10.1016/j.ejrad.2008.01.022. Epub 2008 Mar 14.

PMID:
18343071
11.

On the potential causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis.

Partain CL.

J Magn Reson Imaging. 2007 May;25(5):879-80. No abstract available.

PMID:
17457806
12.

Efficacy and safety of lanthanoids as X-ray contrast agents.

Pietsch H, Jost G, Frenzel T, Raschke M, Walter J, Schirmer H, Hütter J, Sieber MA.

Eur J Radiol. 2011 Nov;80(2):349-56. doi: 10.1016/j.ejrad.2009.10.023. Epub 2009 Dec 16.

PMID:
20006455
13.

Safety of magnetic resonance contrast media.

Runge VM.

Top Magn Reson Imaging. 2001 Aug;12(4):309-14. Review.

PMID:
11687717
14.

Gadolinium-based contrast media and the development of nephrogenic systemic fibrosis in patients with renal insufficiency.

Chewning RH, Murphy KJ.

J Vasc Interv Radiol. 2007 Mar;18(3):331-3. Review. Erratum in: J Vasc Interv Radiol. 2007 Nov;18(11):1463.

PMID:
17377176
15.

Critical in vitro evaluation of responsive MRI contrast agents for calcium and zinc.

Mishra A, Logothetis NK, Parker D.

Chemistry. 2011 Feb 1;17(5):1529-37. doi: 10.1002/chem.201001548. Epub 2011 Jan 5.

PMID:
21268155
16.

Lanthanide ion-doped GdPO4 nanorods with dual-modal bio-optical and magnetic resonance imaging properties.

Ren W, Tian G, Zhou L, Yin W, Yan L, Jin S, Zu Y, Li S, Gu Z, Zhao Y.

Nanoscale. 2012 Jun 21;4(12):3754-60. doi: 10.1039/c2nr30683b. Epub 2012 May 23.

PMID:
22622654
17.

Lanthanide complexes on Ag nanoparticles: designing contrast agents for magnetic resonance imaging.

Siddiqui TS, Jani A, Williams F, Muller RN, Vander Elst L, Laurent S, Yao F, Wadghiri YZ, Walters MA.

J Colloid Interface Sci. 2009 Sep 1;337(1):88-96. doi: 10.1016/j.jcis.2009.04.096. Epub 2009 May 18.

PMID:
19527906
18.

A timely reminder about an evolving clinical entity: nephrogenic systemic fibrosis and gadolinium use in CKD.

Jamboti J.

Nephrology (Carlton). 2007 Jun;12(3):316. No abstract available.

PMID:
17498132
19.

Interactions of lanthanides and their complexes with proteins. Conclusions regarding magnetic resonance imaging.

Aime S, Barge A, Botta M, Terreno E.

Met Ions Biol Syst. 2003;40:643-82. No abstract available.

PMID:
12723161
20.

Clinical value of negative skin tests to gadolinium contrast agents.

Chiriac AM, Audurier Y, Bousquet PJ, Demoly P.

Allergy. 2011 Nov;66(11):1504-6. doi: 10.1111/j.1398-9995.2011.02690.x. Epub 2011 Aug 19. No abstract available.

Supplemental Content

Support Center